Literature DB >> 20148533

Enhancement of hydrophobic interactions and hydrogen bond strength by cooperativity: synthesis, modeling, and molecular dynamics simulations of a congeneric series of thrombin inhibitors.

Laveena Muley1, Bernhard Baum, Michael Smolinski, Marek Freindorf, Andreas Heine, Gerhard Klebe, David G Hangauer.   

Abstract

Accurately predicting the binding affinity of ligands to their receptors by computational methods is one of the major challenges in structure-based drug design. One of the potentially significant errors in these predictions is the common assumption that the ligand binding affinity contributions of noncovalent interactions are additive. Herein we present data obtained from two separate series of thrombin inhibitors containing hydrophobic side chains of increasing size that bind in the S3 pocket and with, or without, an adjacent amine that engages in a hydrogen bond with Gly 216. The first series of inhibitors has a m-chlorobenzyl moiety binding in the S1 pocket, and the second has a benzamidine moiety. When the adjacent hydrogen bond is present, the enhanced binding affinity per A(2) of hydrophobic contact surface in the S3 pocket improves by 75% and 59%, respectively, over the inhibitors lacking this hydrogen bond. This improvement of the binding affinity per A(2) demonstrates cooperativity between the hydrophobic interaction and the hydrogen bond.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20148533     DOI: 10.1021/jm9016416

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  17 in total

Review 1.  Applying thermodynamic profiling in lead finding and optimization.

Authors:  Gerhard Klebe
Journal:  Nat Rev Drug Discov       Date:  2015-01-23       Impact factor: 84.694

2.  Simulations of a protein crystal with a high resolution X-ray structure: evaluation of force fields and water models.

Authors:  David S Cerutti; Peter L Freddolino; Robert E Duke; David A Case
Journal:  J Phys Chem B       Date:  2010-10-14       Impact factor: 2.991

3.  Identification of a novel putative inhibitor of the Plasmodium falciparum purine nucleoside phosphorylase: exploring the purine salvage pathway to design new antimalarial drugs.

Authors:  Luciano Porto Kagami; Gustavo Machado das Neves; Ricardo Pereira Rodrigues; Vinicius Barreto da Silva; Vera Lucia Eifler-Lima; Daniel Fábio Kawano
Journal:  Mol Divers       Date:  2017-05-18       Impact factor: 2.943

4.  Water mediated ligand functional group cooperativity: the contribution of a methyl group to binding affinity is enhanced by a COO(-) group through changes in the structure and thermodynamics of the hydration waters of ligand-thermolysin complexes.

Authors:  Nader N Nasief; Hongwei Tan; Jing Kong; David Hangauer
Journal:  J Med Chem       Date:  2012-09-19       Impact factor: 7.446

5.  A machine learning-based method to improve docking scoring functions and its application to drug repurposing.

Authors:  Sarah L Kinnings; Nina Liu; Peter J Tonge; Richard M Jackson; Lei Xie; Philip E Bourne
Journal:  J Chem Inf Model       Date:  2011-02-03       Impact factor: 4.956

6.  Potentiation of ligand binding through cooperative effects in monoamine oxidase B.

Authors:  Daniele Bonivento; Erika M Milczek; G Reid McDonald; Claudia Binda; Andrew Holt; Dale E Edmondson; Andrea Mattevi
Journal:  J Biol Chem       Date:  2010-09-20       Impact factor: 5.157

Review 7.  A medicinal chemist's guide to molecular interactions.

Authors:  Caterina Bissantz; Bernd Kuhn; Martin Stahl
Journal:  J Med Chem       Date:  2010-07-22       Impact factor: 7.446

8.  Rationalizing tight ligand binding through cooperative interaction networks.

Authors:  Bernd Kuhn; Julian E Fuchs; Michael Reutlinger; Martin Stahl; Neil R Taylor
Journal:  J Chem Inf Model       Date:  2011-12-09       Impact factor: 4.956

9.  How well do the substrates KISS the enzyme? Molecular docking program selection for feruloyl esterases.

Authors:  D B R K Gupta Udatha; Nobuyoshi Sugaya; Lisbeth Olsson; Gianni Panagiotou
Journal:  Sci Rep       Date:  2012-03-20       Impact factor: 4.379

10.  Nonadditivity in public and inhouse data: implications for drug design.

Authors:  D Gogishvili; E Nittinger; C Margreitter; C Tyrchan
Journal:  J Cheminform       Date:  2021-07-02       Impact factor: 5.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.